Wird geladen...
Advances in PSMA theranostics
The validation of prostate specific membrane antigen (PSMA) as a molecular target in metastatic castration-resistant prostate cancer has stimulated the development of multiple classes of theranostic ligands that specifically target PSMA. Theranostic ligands are used to image disease or selectively d...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Elsevier
2022-08-01
|
Schriftenreihe: | Translational Oncology |
Schlagworte: | |
Online Zugang: | http://www.sciencedirect.com/science/article/pii/S1936523322001097 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|